No results found for “”
No results found for filter “”
-
Statements & press releases 04.12.23
Stakeholder coalition calls for legislative refinement of the EHDS
Recommendations to facilitate the resolution of five key challenges that will define the impact of the EHDS and its ability to reach the intended policy...
Read Article -
Statements & press releases 03.12.23
Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
By IFPMA, ABPI, EFPIA, Farmindustria, Innovative Medicines Canada, JPMA, Leem, PhRMA, vfa
Read Article -
Statements & press releases 01.12.23
EFPIA response to EHDS report adopted by ENVI/LIBE committee in the European Parliament
Sharing a range of electronic health data types for secondary purposes through the EHDS can boost research and innovation, improve treatments and care...
Read Article -
Blog articles 29.11.23
How companies are moving patient voices centre stage
Innovative pharmaceutical companies can turn patient engagement into an organisational mindset and practice. Focusing on capacity building is key
Read Article -
Blog articles 29.11.23
Capacity building: How can patient organisations shape the future of drug development?
Patients have a central role to play across the medicine lifecycle – developing the right skills boosts impact and supports sustainability
Read Article -
Statements & press releases 20.11.23
EU pharmaceutical legislation: tackling the AMR innovation challenge for a healthier future
Confronting this complex challenge requires a comprehensive approach, encompassing enhanced surveillance, prudent use, preventive measures, and the development...
Read Article -
Blog articles 20.11.23
AMR case study: cystic fibrosis patients live in fear of infection
Patient advocates in Poland are fighting to improve access to antibiotics and to enhance infection control infrastructure in hospitals
Read Article -
Blog articles 20.11.23
AMR in Central & Eastern Europe: What do patients think?
Antimicrobial resistance (AMR) is highest in central and eastern Europe ‒ we asked patient advocates how they are impacted and what can be done to solve...
Read Article -
Blog articles 07.11.23
Improving men's health standards in Europe: a vital need for action (Guest blog)
As #Movember kicks off, we turn to two experts from the Let’s Talk Prostate Cancer (LTPC) Expert Group to shed light on the state of men's health in Europe....
Read Article -
Statements & press releases 06.11.23
Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk...
New research shows Europe could lose 8% of total pharmaceutical innovation in the next 15 years
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
Statements & press releases 26.10.23
EFPIA statement on the European Commission's Communication on addressing medicine shortages in the EU...
Solutions to address shortages need to be fit for purpose targeting the specific root causes
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article -
EFPIA News 13.07.23
Access to oncology combination therapies in Europe: Today's challenges and solutions
Despite the significant value combination therapies bring to cancer care, there are several challenges to their access in Europe. Without action, some...
Read Article -
EFPIA News 12.06.23
IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
IHI Call Days: Calls 4 & 5
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 04.12.23
Stakeholder coalition calls for legislative refinement of the EHDS
Recommendations to facilitate the resolution of five key challenges that will define the impact of the EHDS and its ability to reach the intended policy...
Read Article -
Statements & press releases 03.12.23
Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
By IFPMA, ABPI, EFPIA, Farmindustria, Innovative Medicines Canada, JPMA, Leem, PhRMA, vfa
Read Article -
Statements & press releases 01.12.23
EFPIA response to EHDS report adopted by ENVI/LIBE committee in the European Parliament
Sharing a range of electronic health data types for secondary purposes through the EHDS can boost research and innovation, improve treatments and care...
Read Article -
Statements & press releases 20.11.23
EU pharmaceutical legislation: tackling the AMR innovation challenge for a healthier future
Confronting this complex challenge requires a comprehensive approach, encompassing enhanced surveillance, prudent use, preventive measures, and the development...
Read Article -
Statements & press releases 06.11.23
Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk...
New research shows Europe could lose 8% of total pharmaceutical innovation in the next 15 years
Read Article -
Statements & press releases 26.10.23
EFPIA statement on the European Commission's Communication on addressing medicine shortages in the EU...
Solutions to address shortages need to be fit for purpose targeting the specific root causes
Read Article -
Statements & press releases 20.10.23
Product Liability Directive: European industry calls for a major rethink
The new proposal may open the door to a litigation culture in Europe.
Read Article -
Statements & press releases 11.10.23
New report urges “rethink of European cancer services” to meet future demand for care
With five new cancer patients diagnosed every minute in Europe, experts estimate that the region will see a shortage of 4.1 million healthcare workers...
Read Article -
Statements & press releases 03.10.23
European Commission’s draft Pharmaceutical Legislation proposals will harm patient access to medicines...
We have to make sure that the legislation works for patients and healthcare systems, and we must also stop and reverse the downward trends in Europe’s...
Read Article -
Statements & press releases 28.09.23
Evidence shows more than 600 essential medicines at risk, and manufacturing in Europe will ‘grind to...
A proposed restriction on the use of fluorinated substances across the EEA could see the widespread shut down of medicines manufacturing, according to...
Read Article -
Statements & press releases 22.09.23
Orphan medicines: How the draft pharmaceutical legislation proposals would impact rare disease patients?...
As currently drafted, the European Commission proposals contained in the revised legislation would discourage the development of 45 rare disease treatments...
Read Article -
Statements & press releases 13.09.23
SOTEU 2023: Reconciling policy and practice
Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 29.11.23
How companies are moving patient voices centre stage
Innovative pharmaceutical companies can turn patient engagement into an organisational mindset and practice. Focusing on capacity building is key
Read Article -
Blog articles 29.11.23
Capacity building: How can patient organisations shape the future of drug development?
Patients have a central role to play across the medicine lifecycle – developing the right skills boosts impact and supports sustainability
Read Article -
Blog articles 20.11.23
AMR case study: cystic fibrosis patients live in fear of infection
Patient advocates in Poland are fighting to improve access to antibiotics and to enhance infection control infrastructure in hospitals
Read Article -
Blog articles 20.11.23
AMR in Central & Eastern Europe: What do patients think?
Antimicrobial resistance (AMR) is highest in central and eastern Europe ‒ we asked patient advocates how they are impacted and what can be done to solve...
Read Article -
Blog articles 07.11.23
Improving men's health standards in Europe: a vital need for action (Guest blog)
As #Movember kicks off, we turn to two experts from the Let’s Talk Prostate Cancer (LTPC) Expert Group to shed light on the state of men's health in Europe....
Read Article -
Blog articles 26.10.23
What is innovation in medicines?
How we define and incentivise medical innovation will shape future waves of medical progress. We need a system where the early-stage research and incremental...
Read Article -
Blog articles 05.10.23
Supporting Europe’s Informal Carers: a call to action for Pharma companies (Guest blog)
Informal carers across the EU play an invaluable role in the healthcare ecosystem. They provide essential physical, emotional and logistical support to...
Read Article -
Blog articles 04.10.23
Precision Medicine and Population Health: a contradiction or a way forward? (Guest blog)
By focusing on individual information and genomics and channeling the right approach to the right patient at the right time, we can reach benefits at population...
Read Article -
Blog articles 26.09.23
Affordability of medicines is a two-sided coin (Guest blog)
Pharmaceutical expenditure has remained stable at around 15% of healthcare spending in most European countries over the past 20 years. Beyond pharmaceutical...
Read Article -
Blog articles 21.09.23
Rethinking Alzheimer's Disease: A Call to Action for Early Detection and Diagnosis
Charting a course to improve early detection and timely diagnosis of Alzheimer’s in Europe
Read Article -
Blog articles 05.09.23
How the pharmaceutical industry is contributing to mitigate climate change
New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies
Read Article -
Blog articles 01.08.23
Lung cancer: meeting patients’ needs through innovation
An inclusive definition of unmet medical need is vital to driving better outcomes for patients
Read Article